Aprea Therapeutics Inc (APRE)
US Market

Aprea Therapeutics (APRE) Stock Price & Analysis


APRE Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.33 - $25.80
Previous Close$3.4
Average Volume (3M)12.48K
Market Cap
Enterprise Value-$18.31M
Total Cash (Recent Filing)$31.00M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.5
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.71
Shares Outstanding3,731,571
10 Day Avg. Volume11,568
30 Day Avg. Volume12,480
Standard Deviation3.13
Financial Highlights & Ratios
Price to Book (P/B)-1.01
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.54
Price Target Upside429.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Aprea Therapeutics Inc’s price range in the past 12 months?
Aprea Therapeutics Inc lowest stock price was $3.33 and its highest was $25.80 in the past 12 months.
    What is Aprea Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Aprea Therapeutics Inc’s upcoming earnings report date?
    Aprea Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 74 days.
      How were Aprea Therapeutics Inc’s earnings last quarter?
      Aprea Therapeutics Inc released its earnings results on May 15, 2023. The company reported -$1.34 earnings per share for the quarter, beating the consensus estimate of -$1.505 by $0.165.
        Is Aprea Therapeutics Inc overvalued?
        According to Wall Street analysts Aprea Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Aprea Therapeutics Inc pay dividends?
          Aprea Therapeutics Inc does not currently pay dividends.
          What is Aprea Therapeutics Inc’s EPS estimate?
          Aprea Therapeutics Inc’s EPS estimate is -$1.43.
            How many shares outstanding does Aprea Therapeutics Inc have?
            Aprea Therapeutics Inc has 3,731,571 shares outstanding.
              What happened to Aprea Therapeutics Inc’s price movement after its last earnings report?
              Aprea Therapeutics Inc reported an EPS of -$1.34 in its last earnings report, beating expectations of -$1.505. Following the earnings report the stock price went up 6.284%.
                Which hedge fund is a major shareholder of Aprea Therapeutics Inc?
                Among the largest hedge funds holding Aprea Therapeutics Inc’s share is Blackstone Inc.. It holds Aprea Therapeutics Inc’s shares valued at 5K.


                  Aprea Therapeutics Stock Smart Score

                  This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Aprea Therapeutics Inc

                  Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded in 2002 and is headquartered in Boston, MA.


                  Top 5 ETFs holding APRE

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold APRE. The ETFs are listed according to market value of APRE within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Neoleukin Therapeutics
                  AgeX Therapeutics
                  Forte Biosciences
                  GeoVax Labs

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis